According to Cosmo Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 36.88%. At the end of 2021 the company had an Operating Margin of 36.89%.
Year | Operating Margin | Change |
---|---|---|
2021 | 36.89% | -424.36% |
2020 | -11.37% | -66.64% |
2019 | -34.09% | 28.12% |
2018 | -26.61% | -44.83% |
2017 | -48.23% | -218.71% |
2016 | 40.63% | -90.32% |
2015 | 419.57% | 206.8% |
2014 | 136.76% | 7.56% |
2013 | 127.15% | 181.54% |
2012 | 45.16% | 66.43% |
2011 | 27.14% | 95.05% |
2010 | 13.91% | -30.18% |
2009 | 19.93% | -41.37% |
2008 | 33.98% | 4764.23% |
2007 | 0.70% | -86.81% |
2006 | 5.30% | -37.34% |
2005 | 8.45% | -176.44% |
2004 | -11.06% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.